Many investors have a type of acrophobia (the fear of heights). It's not that they're worried about standing at the top of a ladder. Instead, their concern is focused on putting money in stocks when the...
Biotechs often need several years to realize their visions, even after they have a drug approved for the first time. There's typically plenty of upside in store for enterprising and patient investors.
Regulators are reviewing what could become a multi-billion-dollar drug.
Both stocks have made significant breakthroughs.
This biotech penny stock could more than triple, based on consensus forecasts.
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +1.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.32%. Stocks rallied on...
The S&P 500 Index ($SPX ) (SPY ) today is up +0.95%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.88%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.08%. Stocks are climbing today, supported...
From blue chip dividend stocks to industry-leading growth stocks, there are plenty of bargains in today's market if you know where to look.
The sky's the limit for these stocks.
VRTX earnings call for the period ending September 30, 2024.